Melanoma Clinical Trials in Copenhagen
2 recruitingCopenhagen, Denmark
Showing 1–2 of 2 trials
Recruiting
Phase 4
Dabrafenib and/or Trametinib Rollover Study
Melanoma
Novartis Pharmaceuticals100 enrolled28 locationsNCT03340506
Recruiting
Phase 2
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
MelanomaSquamous Cell Carcinoma of Head and Neck
IO Biotech60 enrolled15 locationsNCT05280314